{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:16:20Z","timestamp":1775679380637,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.neurol.2020.03.014","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T17:33:28Z","timestamp":1587144808000},"page":"739-749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic and therapeutic issues of inflammatory diseases of the elderly"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-2981","authenticated-orcid":false,"given":"X.","family":"Ayrignac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Carra-Dalli\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Labauge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.03.014_bib0495","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0500","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0505","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2020.03.014_bib0510","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1352458519876031","article-title":"The \u201ccentral vein sign\u201d in patients with diagnostic \u201cred flags\u201d for multiple sclerosis: A prospective multicenter 3T study","volume":"26","author":"Maggi","year":"2020","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neurol.2020.03.014_bib0515","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jnnp-2011-300679","article-title":"Using atypical symptoms and red flags to identify non-demyelinating disease","volume":"83","author":"Kelly","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.03.014_bib0520","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/WNL.0000000000000273","article-title":"CNS inflammation other than multiple sclerosis: how likely is diagnosis?","volume":"82","author":"Street","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0525","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1474-4422(16)30043-6","article-title":"Atypical inflammatory demyelinating syndromes of the CNS","volume":"15","author":"Hardy","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0530","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0535","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0540","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/WCO.0000000000000331","article-title":"Central nervous system inflammation across the age span:","volume":"29","author":"Bar-Or","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0545","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.msard.2018.12.016","article-title":"Camdessanche J-P, et al. First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study","volume":"28","author":"Lavandier","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.03.014_bib0550","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12883-015-0417-y","article-title":"Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population","volume":"15","author":"Mao","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0555","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/1352458516634871","article-title":"Aging and multiple sclerosis","volume":"22","author":"Sanai","year":"2016","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neurol.2020.03.014_bib0560","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10522-015-9578-8","article-title":"Inflammaging decreases adaptive and innate immune responses in mice and humans","volume":"17","author":"Frasca","year":"2016","journal-title":"Biogerontology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0565","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fnins.2015.00172","article-title":"Immune aging, dysmetabolism, and inflammation in neurological diseases","volume":"9","author":"Deleidi","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurol.2020.03.014_bib0570","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?","volume":"8","author":"Fulop","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0575","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1474-4422(14)70093-6","article-title":"Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research","volume":"13","author":"Waldman","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0580","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1212\/01.wnl.0000237475.01655.9d","article-title":"Is late-onset multiple sclerosis associated with a worse outcome?","volume":"67","author":"Tremlett","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0585","first-page":"1082","article-title":"[Late onset multiple sclerosis]","volume":"158","author":"Delalande","year":"2002","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2020.03.014_bib0590","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1468-1331.2004.01103.x","article-title":"Brain MRI in late-onset multiple sclerosis","volume":"12","author":"de Seze","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0595","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0600","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.msard.2014.02.004","article-title":"Late onset multiple sclerosis: Is it really late onset?","volume":"3","author":"Roohani","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.03.014_bib0605","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1352458518815602","article-title":"Observatoire Fran\u00e7ais de la Scl\u00e9rose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France","volume":"26","author":"Vukusic","year":"2020","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neurol.2020.03.014_bib0610","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/ene.13745","article-title":"Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study","volume":"25","author":"D\u2019Amico","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0615","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00415-008-0778-x","article-title":"Clinical characteristics of patients with late-onset multiple sclerosis","volume":"255","author":"Kis","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0620","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0404.1985.tb01547.x","article-title":"Late onset multiple sclerosis. A clinical study of 16 pathologically proven cases","volume":"72","author":"Lyon-Caen","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2020.03.014_bib0625","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2013-306573.26","article-title":"Late\u2013onset multiple sclerosis in South\u2013East Wales","volume":"84","author":"Harding","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.03.014_bib0630","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/0004-282x20170070","article-title":"Late onset multiple sclerosis: concerns in aging patients","volume":"75","author":"Lotti","year":"2017","journal-title":"Arq Neuropsyquiatr"},{"key":"10.1016\/j.neurol.2020.03.014_bib0635","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis Spectrum Disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.neurol.2020.03.014_bib0640","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","article-title":"B cells and antibodies in multiple sclerosis pathogenesis and therapy","volume":"8","author":"Krumbholz","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0645","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0650","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0655","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1352458513499420","article-title":"Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica","volume":"20","author":"Zhang","year":"2014","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0660","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0665","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0670","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458513515085","article-title":"Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset","volume":"20","author":"Collongues","year":"2014","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0675","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0680","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","article-title":"Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies","volume":"70","author":"Kitley","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0685","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neurol.2020.03.014_bib0690","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1177\/1352458517705479","article-title":"Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: two new cases","volume":"23","author":"Zhang","year":"2017","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neurol.2020.03.014_bib0695","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaneurol.2016.5441","article-title":"Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0700","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/jnnp-2019-320493","article-title":"Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up","volume":"90","author":"Petzold","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.03.014_bib0705","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","article-title":"Antibodies to Aquaporin 4, Myelin-Oligodendrocyte Glycoprotein, and the Glycine Receptor \u03b11 Subunit in Patients With Isolated Optic Neuritis","volume":"72","author":"Martinez-Hernandez","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0710","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1352458518813105","article-title":"Area postrema syndrome: a short history of a pearl in demyelinating diseases","volume":"25","author":"Camara-Lemarroy","year":"2019","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neurol.2020.03.014_bib0715","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318214332c","article-title":"Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications","volume":"76","author":"Popescu","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0720","series-title":"Encephalitis is an important clinical component of. pdf, Eur J Neurol;26","first-page":"168","author":"Wang.","year":"2019"},{"key":"10.1016\/j.neurol.2020.03.014_bib0725","series-title":"Myelin oligodendrocyte glycoprotein antibody-assoc. pdf. Eur J Neurol;26","first-page":"175","author":"Zhou","year":"2019"},{"key":"10.1016\/j.neurol.2020.03.014_bib0730","series-title":"Clinical, Radiologic, and Prognostic Features of M.pdf. JAMA Neurol; 76","first-page":"301","author":"Dubey","year":"2019"},{"key":"10.1016\/j.neurol.2020.03.014_bib0735","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1212\/NXI.0000000000000543","article-title":"Cranial nerve involvement in patients with MOG antibody-associated disease","volume":"6","author":"Cobo-Calvo","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neurol.2020.03.014_bib0740","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/ebmental-2019-300110","article-title":"Autoimmune encephalitis in the elderly: who to test and what to test for","volume":"22","author":"Behrman","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.neurol.2020.03.014_bib0745","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis: Autoimmune Encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0750","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0755","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/WNL.0000000000002723","article-title":"Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study","volume":"86","author":"Koelman","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0760","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0765","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000338630.20412.45","article-title":"Role of MRI in the differentiation of ADEM from MS in children","volume":"72","author":"Callen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0770","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/archneur.64.10.1426","article-title":"Acute fulminant demyelinating disease: a descriptive study of 60 patients","volume":"64","author":"de Seze","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0775","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1212\/WNL.0b013e3181dc138b","article-title":"A comparison of MRI criteria for diagnosing pediatric ADEM and MS","volume":"74","author":"Ketelslegers","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0780","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s00415-017-8563-3","article-title":"Acute disseminated encephalomyelitis: prognostic value of early follow-up brain MRI","volume":"264","author":"Koelman","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0785","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG\u2013Associated Disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0790","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.msard.2019.03.018","article-title":"A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion","volume":"31","author":"Miyaue","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.03.014_bib0795","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients: Autoimmune GFAP Astrocytopathy","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0800","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0805","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"astrocytopathy: Prospective evaluation of 90 patients in 1\u00a0year","volume":"321","author":"Dubey","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0810","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","article-title":"Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients","volume":"89","author":"Iorio","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.03.014_bib0815","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.21226","article-title":"Primary central nervous system vasculitis: analysis of 101 patients","volume":"62","author":"Salvarani","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0820","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/art.38340","article-title":"Primary Angiitis of the Central Nervous System: Description of the First Fifty-Two Adults Enrolled in the French Cohort of Patients With Primary Vasculitis of the Central Nervous System: Findings in a French Cohort of Patients With PACNS","volume":"66","author":"de Boysson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0825","first-page":"1","article-title":"l. Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: A comparative study","author":"de Boysson","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0830","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1474-4422(11)70081-3","article-title":"Primary angiitis of the CNS","volume":"10","author":"Hajj-Ali","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0835","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ana.24652","article-title":"Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison: RCVS and PACNS","volume":"79","author":"Singhal","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0840","unstructured":"Boulouis G, de Boysson H, Zuber M, Guillevin L, Meary E, Costalat V, et al. Primary Angiitis of the Central Nervous System n.d.:18."},{"key":"10.1016\/j.neurol.2020.03.014_bib0845","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.msard.2019.05.012","article-title":"Susceptibility-weighted imaging in the differential diagnosis of autoimmune central nervous system vasculitis and multiple sclerosis","volume":"33","author":"Huang","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.03.014_bib0850","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3174\/ajnr.A2477","article-title":"Evaluation of parenchymal neuro-beh\u00e7et disease by using susceptibility-weighted imaging","volume":"32","author":"Albayram","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0855","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0860","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3174\/ajnr.A1470","article-title":"Correlation of MR Imaging Findings and Clinical Manifestations in Neurosarcoidosis","volume":"30","author":"Shah","year":"2009","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0865","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jamaneurol.2017.2492","article-title":"Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis","volume":"74","author":"Joubert","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0870","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awn098","article-title":"Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis","volume":"131","author":"Lucchinetti","year":"2008","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0875","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1148\/radiol.2512072071","article-title":"Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging","volume":"251","author":"Kim","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0880","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3174\/ajnr.A3677","article-title":"Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions","volume":"35","author":"Lu","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0885","article-title":"CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma","author":"Ikeguchi","year":"2017","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0890","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/brain\/awu397","article-title":"Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis","volume":"138","author":"Weisfeld-Adams","year":"2015","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0895","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1352458515596458","article-title":"risk under immunotherapy: if all you have is a hammer, everything looks like a nail","volume":"22","author":"Van Schependom","year":"2016","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0900","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.tips.2015.09.006","article-title":"PML: the dark side of immunotherapy in multiple sclerosis","volume":"36","author":"Warnke","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurol.2020.03.014_bib0905","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/jnnp-2018-318957","article-title":"CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS","volume":"90","author":"Taieb","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.03.014_bib0910","doi-asserted-by":"crossref","first-page":"101487","DOI":"10.1016\/j.msard.2019.101487","article-title":"The frequency of longitudinally extensive transverse myelitis in MS: A population-based study","volume":"37","author":"Asnafi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.03.014_bib0915","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archneurol.2011.949","article-title":"Long-term follow-up of acute partial transverse myelitis","volume":"69","author":"Bourre","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0920","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1212\/WNL.0000000000008479","article-title":"Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases","volume":"93","author":"Mariotto","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0925","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00234-015-1629-y","article-title":"Punctate and curvilinear gadolinium enhancing lesions in the brain: a practical approach","volume":"58","author":"Taieb","year":"2016","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0930","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1212\/WNL.0000000000005256","article-title":"Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD","volume":"90","author":"Cortese","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0935","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0940","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arr.2017.10.005","article-title":"The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)","volume":"41","author":"Bolton","year":"2018","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.neurol.2020.03.014_bib0945","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1007\/s11357-014-9729-x","article-title":"Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease","volume":"36","author":"Bueno","year":"2014","journal-title":"Age Dordr Neth"},{"key":"10.1016\/j.neurol.2020.03.014_bib0950","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1212\/WNL.0000000000004885","article-title":"Effects of physical comorbidities on disability progression in multiple sclerosis","volume":"90","author":"Zhang","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.014_bib0955","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11910-017-0800-8","article-title":"Infections in patients receiving multiple sclerosis disease-modifying therapies","volume":"17","author":"Grebenciucova","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neurol.2020.03.014_bib0960","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1352458516670732","article-title":"Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections?","volume":"23","author":"Carpenter","year":"2017","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0965","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/1352458517693440","article-title":"Opportunistic infections after alemtuzumab: New cases of norcardial infection and cytomegalovirus syndrome","volume":"23","author":"Brownlee","year":"2017","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.neurol.2020.03.014_bib0970","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s13365-017-0561-9","article-title":"Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy","volume":"23","author":"Prosperini","year":"2017","journal-title":"J Neurovirol"},{"key":"10.1016\/j.neurol.2020.03.014_bib0975","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jbspin.2017.12.014","article-title":"Pulmonary arterial hypertension in four patients treated by leflunomide","volume":"85","author":"Coirier","year":"2018","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"10.1016\/j.neurol.2020.03.014_bib0980","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2042098613481023","article-title":"Fingolimod and cardiac risk: latest findings and clinical implications","volume":"4","author":"Vargas","year":"2013","journal-title":"Ther Adv Drug Saf"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720305129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720305129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:42:34Z","timestamp":1758519754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720305129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":98,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0035378720305129"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.03.014","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and therapeutic issues of inflammatory diseases of the elderly","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}